PT Kalbe Farma Tbk (PTKFF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
PT Kalbe Farma Market Cap : 2.371B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.371B |
| October 08, 2026 | 2.371B |
| October 07, 2026 | 2.371B |
| October 06, 2026 | 2.371B |
| October 05, 2026 | 2.371B |
| October 02, 2026 | 2.371B |
| October 01, 2026 | 2.371B |
| September 30, 2026 | 2.371B |
| September 29, 2026 | 2.371B |
| September 28, 2026 | 2.371B |
| September 25, 2026 | 2.371B |
| September 24, 2026 | 2.371B |
| September 23, 2026 | 2.371B |
| September 22, 2026 | 2.371B |
| September 21, 2026 | 2.371B |
| September 18, 2026 | 2.371B |
| September 17, 2026 | 2.371B |
| September 16, 2026 | 2.371B |
| September 15, 2026 | 2.371B |
| September 14, 2026 | 2.371B |
| September 11, 2026 | 2.371B |
| September 10, 2026 | 2.371B |
| September 09, 2026 | 2.371B |
| September 08, 2026 | 2.371B |
| September 04, 2026 | 2.371B |
| Date | Value |
|---|---|
| September 03, 2026 | 2.371B |
| September 02, 2026 | 2.371B |
| September 01, 2026 | 2.371B |
| August 31, 2026 | 2.371B |
| August 28, 2026 | 2.371B |
| August 27, 2026 | 2.371B |
| August 26, 2026 | 2.371B |
| August 25, 2026 | 2.371B |
| August 24, 2026 | 2.371B |
| August 21, 2026 | 2.371B |
| August 20, 2026 | 2.371B |
| August 19, 2026 | 1.821B |
| August 18, 2026 | 1.821B |
| August 17, 2026 | 1.821B |
| August 14, 2026 | 1.821B |
| August 13, 2026 | 1.821B |
| August 12, 2026 | 1.821B |
| August 11, 2026 | 1.821B |
| August 10, 2026 | 1.821B |
| August 07, 2026 | 1.821B |
| August 06, 2026 | 1.821B |
| August 05, 2026 | 1.821B |
| August 04, 2026 | 1.821B |
| August 03, 2026 | 1.821B |
| July 31, 2026 | 1.821B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 493.79B |
| ANI Pharmaceuticals, Inc. | 1.697B |
| Corcept Therapeutics, Inc. | 13.08B |
| Veru, Inc. | 41.94M |
| Avadel Pharmaceuticals Plc | 2.104B |
Market Cap Related Metrics
| PE Ratio | 11.15 |
| PS Ratio | 1.060 |
| PEG Ratio | 5.128 |
| Price to Book Value | 1.743 |
| Price to Free Cash Flow | 16.34 |
| Price | 0.0524 |
| Earnings Yield | 8.97% |
| PEGY Ratio | 2.586 |
| Operating PE Ratio | 8.734 |
| Normalized PE Ratio | 11.15 |